The DOI matches its Crossref record; 258 of the 258 references it cites were found in a registry or an index.
Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
Open accessAbstract
The critical role of angiogenesis in promoting tumor growth and metastasis is strongly established. However, tumors show considerable variation in angiogenic characteristics and in their sensitivity to antiangiogenic therapy. Tumor angiogenesis involves not only cancer cells but also various tumor-associated leukocytes (TALs) and stromal cells. TALs produce chemokines, cytokines, proteases, structural proteins, and microvescicles. Vascular endothelial growth factor (VEGF) and inflammatory chemokines are not only major proangiogenic factors but are also immune modulators, which increase angiogenesis and lead to immune suppression. In our review, we discuss the regulation of angiogenesis by innate immune cells in the tumor microenvironment, specific features, and roles of major players: macrophages, neutrophils, myeloid-derived suppressor and dendritic cells, mast cells, γδT cells, innate lymphoid cells, and natural killer cells. Anti-VEGF or anti-inflammatory drugs could balance an immunosuppressive microenvironment to an immune permissive one. Anti-VEGF as well as anti-inflammatory drugs could therefore represent partners for combinations with immune checkpoint inhibitors, enhancing the effects of immune therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–258 of 258
Li, Q., Liu, L., Zhang, Q., Liu, S., Ge, D., & You, Z. (2014) · Cancer Research and Treatment · doi:10.4143/crt.2014.46.3.297 · Cited by 103
Killers become builders during pregnancy
Bouteiller, P. P. L., & Tabiasco, J. (2006) · Nature Medicine · doi:10.1038/nm0906-991 · Cited by 102
Wang, Z., Lai, Y., Bernard, J. J., MacLeod, D. T., Cogen, A. L., Moss, B., & Nardo, A. D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101703 · Cited by 102
Markers and function of human NK cells in normal and pathological conditions
del Zotto, G., Marcenaro, E., Vacca, P., Sivori, S., Pende, D., Chiesa, M. D., Moretta, F., Ingegnere, T., Mingari, M., Moretta, A., et al. (2017) · Cytometry. Part B, Clinical cytometry · doi:10.1002/cyto.b.21508 · Cited by 100
The effects of metformin on gut microbiota and the immune system as research frontiers
Pollak, M. (2017) · Diabetologia · doi:10.1007/s00125-017-4352-x · Cited by 98
PPARα Deficiency in Inflammatory Cells Suppresses Tumor Growth
Kaipainen, A., Kieran, M. W., Huang, S., Butterfield, C., Bielenberg, D. R., Mostoslavsky, G., Mulligan, R. C., Folkman, J., & Panigrahy, D. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000260 · Cited by 98
Induction of Bv8 Expression by Granulocyte Colony-stimulating Factor in CD11b+Gr1+ Cells
Qu, X., Zhuang, G., Yu, L., Meng, G., & Ferrara, N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.326801 · Cited by 96
Park, J., Lee, S. E., Hur, J., Hong, E. B., Choi, J.-I., Yang, J.-M., Kim, J., Kim, Y. C., Cho, H., Peters, J. M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.024 · Cited by 95
Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients
Ranieri, G. (2009) · International Journal of Oncology · doi:10.3892/ijo_00000319 · Cited by 95
Wu, X., Giobbie‐Hurder, A., Liao, X., Lawrence, D. P., McDermott, D. F., Zhou, J. M., Rodig, S. J., & Hodi, F. S. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0084 · Cited by 94
Cantoni, C., Huergo-Zapico, L., Parodi, M., Pedrazzi, M., Mingari, M. C., Moretta, A., Sparatore, B., Gonzalez, S. R., Olive, D., Bottino, C., et al. (2016) · Journal of Immunology Research · doi:10.1155/2016/4684268 · Cited by 91
Chen, Y., Liu, Y.-C., Sung, Y., Ramjiawan, R. R., Lin, T.-T., Chang, C.-C., Jeng, K., Chang, C.-F., Liu, C.-H., Gao, D.-Y., et al. (2017) · Scientific Reports · doi:10.1038/srep44123 · Cited by 85
Monteghirfo, S., Tosetti, F., Ambrosini, C., Stigliani, S., Pozzi, S., Frassoni, F., Fassina, G., Soverini, S., Albini, A., & Ferrari, N. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0132 · Cited by 81
Self-citationTargeting Mast Cells Tryptase in Tumor Microenvironment: A Potential Antiangiogenetic Strategy
Ammendola, M., Leporini, C., Marech, I., Gadaleta, C. D., Scognamillo, G., Sacco, R., Sammarco, G., Sarro, G. D., Russo, E., & Ranieri, G. (2014) · BioMed Research International · doi:10.1155/2014/154702 · Cited by 81
Targeted Therapy and Immunosuppression in the Tumor Microenvironment
Allegrezza, M. J., & Conejo-Garcia, J. R. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.11.009 · Cited by 80
Loffredo, S., Borriello, F., Iannone, R., Ferrara, A. L., Galdiero, M. R., Gigantino, V., Esposito, P. B., Varricchi, G., Lambeau, G. J., Cassatella, M. A., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00443 · Cited by 79
Chen, Y., Li, C., Xie, H., et al. (2017) · Oncogene · doi:10.1038/onc.2016.442 · Cited by 76
Porta, C., Sica, A., & Riboldi, E. (2017) · FEBS Journal · doi:10.1111/febs.14288 · Cited by 72
Wu, X., Li, J., Connolly, E. M., Liao, X., Ouyang, J., Giobbie‐Hurder, A., Lawrence, D. P., McDermott, D. F., Murphy, G. F., Zhou, J. M., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0385 · Cited by 71
Mast Cells Contribute to Vasculogenic Mimicry in Multiple Myeloma
Nico, B., Mangieri, D., Enrico Crivellato, B., Vacca, A., & Ribatti, D. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0132 · Cited by 67
The 'T-cell-ness' of NK cells: unexpected similarities between NK cells and T cells
Narni-Mancinelli, É., Vivier, É., & Kerdiles, Y. M. (2011) · International Immunology · doi:10.1093/intimm/dxr035 · Cited by 66
Putz, E. M., Guillerey, C., Kos, K., Stannard, K. A., Miles, K. M., Delconte, R. B., Takeda, K., Nicholson, S. E., Huntington, N. D., & Smyth, M. J. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1267892 · Cited by 65
State-of-the-art of regulatory dendritic cells in cancer
Conejo-Garcia, J. R., Rutkowski, M. R., & Cubillos‐Ruiz, J. R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.003 · Cited by 64
Ammendola, M., Sacco, R., Sammarco, G., Donato, G., Montemurro, S., Ruggieri, E., Patruno, R., Marech, I., Cariello, M., Vacca, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099512 · Cited by 63
Zhang, J., Sud, S., Mizutani, K., Gyetko, M. R., & Pienta, K. J. (2011) · Neoplasia · doi:10.1593/neo.10728 · Cited by 60
Santoni, A., Zingoni, A., Cerboni, C., & Gismondi, A. (2007) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2007.00513.x · Cited by 59
Cancer Prevention and Interception: A New Era for Chemopreventive Approaches
Albini, A., DeCensi, A., Cavalli, F., & Costa, A. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0695 · Cited by 58
Self-citationIL-17–Secreting γδ T Cells Are Completely Dependent upon CCR6 for Homing to Inflamed Skin
Campbell, J. J., Ebsworth, K., Ertl, L. S., McMahon, J. P., Newland, D., Wang, Y., Liu, S., Miao, Z., Dang, T., Zhang, P., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700826 · Cited by 57
Talarico, G., Orecchioni, S., Dallaglio, K., Reggiani, F., Mancuso, P., Calleri, A., Gregato, G., Labanca, V., Rossi, T., Noonan, D. M., et al. (2016) · Scientific Reports · doi:10.1038/srep18673 · Cited by 56
Self-citationAllavena, P., Germano, G., Belgiovine, C., D’Incalci, M., & Mantovani, A. (2013) · OncoImmunology · doi:10.4161/onci.24614 · Cited by 55
Chen, X., Xie, Q., Cheng, X., Diao, X., Cheng, Y., Liu, J., Xie, W., Chen, Z., & Zhu, B. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01684.x · Cited by 55
Gill, D. M., Hahn, A. W., Hale, P., & Maughan, B. L. (2018) · Current Treatment Options in Oncology · doi:10.1007/s11864-018-0517-1 · Cited by 54
Neutrophils and Angiogenesis: Potential Initiators of the Angiogenic Cascade
Benelli, R., Albini, A., & Noonan, D. M. (2003) · KARGER eBooks · doi:10.1159/000071560 · Cited by 53
Self-citationThe Jekyll and Hyde story of IL17-Producing γδT Cells
Patil, R. S., Bhat, S. A., Dar, A. A., & Chiplunkar, S. V. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00037 · Cited by 52
Friend or Foe? The Ambiguous Role of Innate Lymphoid Cells in Cancer Development
Mattner, J., & Wirtz, S. J. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.10.004 · Cited by 48
Brencicova, E., Jagger, A. L., Evans, H. G., Georgouli, M., Laios, A., Montalto, S. A., Mehra, G., Spencer, J., Ahmed, A. A., Raju-Kankipati, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175712 · Cited by 48
Effect of xanthohumol on Th1/Th2 balance in a breast cancer mouse model
Zhang, W., Pan, Y., Gou, P., Zhou, C., Ma, L., Liu, Q., Du, Y., Yang, J., & Wang, Q. (2017) · Oncology Reports · doi:10.3892/or.2017.6094 · Cited by 48
Plasticity in mast cell responses during bacterial infections
Chan, C. Y., John, A. L. S., & Abraham, S. N. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.10.007 · Cited by 46
Zhang, B., Zhang, Y., Zhao, J., Wang, Z., Wu, T., Ou, W., Wang, J., Yang, B., Zhao, Y. X., Rao, Z., et al. (2014) · Medical Oncology · doi:10.1007/s12032-014-0127-0 · Cited by 45
Innate Lymphoid Cells in Cancer
Vallentin, B., Barlogis, V., Pipéroglou, C., Cypowyj, S., Zucchini, N., Chéné, M., Navarro, F., Farnarier, C., Vivier, É., & Vely, F. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0222 · Cited by 44
Energy metabolism drives myeloid-derived suppressor cell differentiation and functions in pathology
Sica, A., & Strauss, L. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr1116-476r · Cited by 42
Reflections on immunological nomenclature: in praise of imperfection
Mantovani, A. (2016) · Nature Immunology · doi:10.1038/ni.3354 · Cited by 41
Innate Lymphoid Cells in Tumor Immunity
van Beek, J. J. P., Martens, A. W. J., Bakdash, G., & de Vries, I. J. M. (2016) · Biomedicines · doi:10.3390/biomedicines4010007 · Cited by 40
Metabolic regulation of suppressive myeloid cells in cancer
Sica, A., Strauss, L., Consonni, F. M., Travelli, C., Genazzani, A. A., & Porta, C. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.05.002 · Cited by 40
Bruno, A., Pagani, A., Magnani, E., Rossi, T., Noonan, D. M., Cantelmo, A. R., & Albini, A. (2013) · Cancer treatment and research · doi:10.1007/978-3-642-38007-5_23 · Cited by 37
Self-citationThe Yin and Yang of Innate Lymphoid Cells in Cancer
Carrega, P., Campana, S., Bonaccorsi, I., & Ferlazzo, G. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.06.003 · Cited by 37
CDDO-Me Redirects Activation of Breast Tumor Associated Macrophages
Ball, M. S., Shipman, E. P., Kim, H. J., Liby, K. T., & Pioli, P. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149600 · Cited by 34
Fitzpatrick, L. R., Stonesifer, E., Small, J. S., & Liby, K. T. (2014) · Inflammopharmacology · doi:10.1007/s10787-014-0203-2 · Cited by 33
Ammendola, M., Patruno, R., Sacco, R., Marech, I., Sammarco, G., Zuccalà, V., Luposella, M., Zizzo, N., Gadaleta, C., Porcelli, M., et al. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1158811 · Cited by 32
Albini, A., Bassani, B., Baci, D., Dallaglio, K., Gallazzi, M., Corradino, P., Bruno, A., & Noonan, D. M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666170920144130 · Cited by 32
Self-citationDiet-Derived Phytochemicals: From Cancer Chemoprevention to Cardio-Oncological Prevention
Ferrari, N., Tosetti, F., Flora, S. D., Donatelli, F., Sogno, I., Noonan, D. M., & Albini, A. (2011) · Current Drug Targets · doi:10.2174/138945011798184227 · Cited by 31
Self-citationImmune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1
Hoeres, T., Wilhelm, M., Smetak, M., Holzmann, E., Schulze-Tanzil, G. G., & Birkmann, J. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.13090 · Cited by 31
Dendritic cell rehab: new strategies to unleash therapeutic immunity in ovarian cancer
Chae, C.-S., Terán-Cabanillas, E., & Cubillos‐Ruiz, J. R. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-1958-2 · Cited by 27
Mortara, L., Benest, A. V., Bates, D. O., & Noonan, D. M. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.05.009 · Cited by 27
Self-citationInnate lymphoid cells involve in tumorigenesis
Tian, Z., van Velkinburgh, J. C., Wu, Y., & Ni, B. (2015) · International Journal of Cancer · doi:10.1002/ijc.29443 · Cited by 20
Jachetti, E., Rigoni, A., Bongiovanni, L., Arioli, I., Botti, L., Parenza, M., Cancila, V., Chiodoni, C., Festinese, F., Bellone, M., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0466 · Cited by 19
Leal, A. S., Sporn, M. B., Pioli, P. A., & Liby, K. T. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw099 · Cited by 12
Correlation of Mast Cell Density With Angiogenic Cytokines in Patients With Active Multiple Myeloma
Vyzoukaki, R., Tsirakis, G., Pappa, C. A., Androulakis, N. E. M., Kokonozaki, M., Tzardi, M. N., & Alexandrakis, M. G. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.11.022 · Cited by 7
Cited by
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Farhood, B., Najafi, M., & Mortezaee, K. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27782 · Cited by 1,658
Neutrophil diversity and plasticity in tumour progression and therapy
Jaillon, S., Ponzetta, A., Di Mitri, D., Santoni, A., Bonecchi, R., & Mantovani, A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0281-y · Cited by 1,285
Extracellular matrix (ECM) stiffness and degradation as cancer drivers
Najafi, M., Farhood, B., & Mortezaee, K. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27681 · Cited by 715
Lee, W. S., Yang, H., Chon, H. J., & Kim, C. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00500-y · Cited by 688
Metadata
- Authors
- Albini, A., Bruno, A., Noonan, D. M., & Mortara, L.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-04-05
- Volume
- 9
- Pages
- 527-527
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2796271069
- Cited by
- 392
- References
- 258
- FWCI
- 15.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.